COMP <GO>
ILMN vs GH // EV/EBITDA & P/E VALUATION
Illumina Inc. (NASDAQ) VS. Guardant Health Inc. (NASDAQ) • 15-METRIC TALLY: ILMN 9
— GH 3
■ METRIC PARITY
LAST: $235.99 (-18.64%) • MKT CAP: $43.80B
valuation
47.5x
LAST: $178.80 (-3.51%) • MKT CAP: $24.87B
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ILMN VS. GH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ILMN | GH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 66.10% | 64.50% | +1.60 | ILMN | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 18.20% | -17.40% | +35.60 | ILMN | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 47.5x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 2.13% | -0.94% | +3.07 | ILMN | /fcf-yield <GO> |
| Operating Margin | 18.60% | -44.50% | +63.10 | ILMN | /operating-margins <GO> |
| Net Profit Margin | 19.60% | -42.40% | +62.00 | ILMN | /net-margins <GO> |
| Revenue Growth (YoY) | -0.70% | 32.90% | -33.60 | GH | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 9.52 | 5.44 | +4.08 | ILMN | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 6/9 | +2.00 | ILMN | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 57.1 | 62.0 | -4.90 | GH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.16 | 0.87 | +0.29 | ILMN | /macro-sensitivity <GO> |
| Forward P/E Multiple | 47.9x | 19.0x | +28.90 | GH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $43.80B | $24.87B | $18.93B | ILMN | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ILMN REV | GH REV | ILMN GROSS % | GH GROSS % | ILMN FCF | GH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $4.34B | $982.0M | 66.1% | 64.5% | $931.0M | -$233.1M |
| FY 2024 | $4.37B | $739.0M | 65.4% | 60.8% | $709.0M | -$274.9M |
| FY 2023 | $4.50B | $563.9M | — | — | $275.3M | -$350.4M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ILMN // BETA 1.16
GH // BETA 0.87